NeuroRPM
Overview
NeuroRPM, developed by New Touch Digital Inc., is an AI-enabled remote patient monitoring platform designed to track and analyze motor symptoms in patients with Parkinson’s disease. Utilizing consumer-facing hardware, the software runs on the Apple Watch and mobile devices to continuously and passively collect movement data during wake periods.
The technology is primarily utilized by:
- Neurologists and Movement Disorder Specialists: To remotely monitor patients in outpatient care settings, supporting clinical decision-making and treatment discussions.
- Clinical Researchers and Pharmaceutical Partners: To gather objective, longitudinal digital biomarker data and evaluate treatment responses during clinical trials.
In a clinical workflow, the physician prescribes the application (NeuroRPM-Rx) to the patient. The software operates in the background to detect and quantify core Parkinson’s symptoms, specifically bradykinesia, tremor, and dyskinesia. The platform integrates medication tracking, allowing clinicians to view symptom patterns in relation to daily medication schedules. This objective data is compiled into reports, helping care teams evaluate disease progression, assess medication efficacy, and adjust treatment plans without relying solely on patient self-reporting.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered, real-time detection and visualization of bradykinesia, tremors, and dyskinesias from Apple Watch
- Medication tracking and insights
- HealthKit Integration for holistic wellness monitoring
- Collects accelerometer and gyroscope data from Apple Watch
- Analyzes motion data using machine learning models to generate binary symptom classifications every 15 minutes
- Provides monthly reports
- Companion Mode for sharing health information with family/caregivers (with consent)
Use Cases
- Quantifying movement disorder symptoms in Parkinson's disease patients (tremor, bradykinesia, dyskinesia)
- Medication management for Parkinson's disease
- Remote patient monitoring in clinic and home environments
- Therapy research and development for symptom control and disease modification
- Supporting data-driven care and improving patient management in neurology practices
What Physicians Need to Know
Physicians can leverage NeuroRPM to gain objective, continuous, real-world data on Parkinson's disease motor symptoms (bradykinesia, tremor, dyskinesia) beyond episodic clinic visits. This granular insight can inform more precise medication adjustments, evaluate treatment efficacy, and enhance patient engagement in their disease management. The monthly reports generated by the app provide a detailed chart of symptoms and medication usage, aiding in productive conversations and data-driven clinical decisions. [2, 6, 15]
NeuroRPM integrates seamlessly with the Apple Watch for passive data collection of movement, and with the iPhone for symptom visualization and medication management. [1, 2, 9, 10, 12] It also features integration with Apple HealthKit to provide a holistic view of patient health. [1, 2, 9] The platform is also utilized in clinical trials for pharmaceutical and medical device research, offering objective monitoring of Parkinson's symptoms. [1, 6, 8, 15]
Details
| Category | Neurology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Subscription (via prescription) — Prescription-based subscription model |
| Deployment | Mobile application (iOS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated FDA 510(k) cleared (K221772) on March 17, 2023. NeuroRPM is a software application for the Apple Watch, prescribed by a health professional, intended to quantify movement disorder symptoms (tremor, bradykinesia, and dyskinesia) during wake periods in adult patients 46 to 85 years of age with Parkinson's disease. It is intended for clinic and home environments. |
| Integrations | |
| EHR | Not specified |
| Specialties | Geriatrics, Neurology |
What the Web Says
NeuroRPM is an FDA-cleared, AI-powered Apple Watch app designed for remote patient monitoring of Parkinson's disease symptoms, including tremor, bradykinesia, and dyskinesia. It provides objective, quantitative data to both patients and physicians, aiming to offer insights into medication efficacy and disease progression beyond what subjective patient recall or brief clinical visits can provide. The app is available by prescription only and integrates with HealthKit.
Overall: PositiveStrengths
- Provides objective and quantitative data on Parkinson's symptoms, which is more reliable than subjective patient accounts.
- FDA-cleared, indicating a level of regulatory approval and validation.
- Leverages the Apple Watch for passive, continuous monitoring, requiring minimal user interaction.
- Offers detailed daily and monthly reports that can be shared with neurologists to inform treatment decisions.
- Responsive technical support team that actively incorporates user feedback.
- Potential to revolutionize Parkinson's care by providing unprecedented insights and enabling more informed clinical decisions.
Limitations
- Some users have reported issues with the initial setup process and a lack of response from support for these issues.
- The lack of detailed information on the proprietary algorithms used is a drawback for some.
- One Reddit user found that continuously tracking symptoms negatively impacted their mental health.
- Pricing information for the monthly subscription is not readily available.
- A study noted that there is no scientific evidence apart from the FDA clearance summary report, which involved a relatively small study group of 36 patients.
Based on reviews from: App Store - Apple, FDA, ParkiesUnite, PCLA, PMC, Reddit
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
